Genpact Limited G is expected to report its second quarter 2023 financial results, after the closing bell on Aug. 9, 2023.
Analysts expect the company to post quarterly earnings at 69 cents per share, down from year-ago earnings of 70 cents per share. The company’s revenue might come in at $1.12 billion, up from $1.09 billion in the year-ago period.
Genpact shares fell 1.6% to close at $35.66 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Citigroup analyst Ashwin Shirvaikar downgraded the stock from Buy to Neutral and cut the price target from $46 to $42 on July 18, 2023. This analyst has an accuracy rate of 75%.
- Wedbush analyst Moshe Katri reiterated a Neutral rating with a price target of $45 on June 7, 2023. This analyst has an accuracy rate of 66%.
- Jefferies analyst Surinder Thind maintained a Hold rating and cut the price target from $47 to $41 on May 15, 2023. This analyst has an accuracy rate of 73%.
- BMO Capital analyst Keith Bachman maintained a Market Perform rating and cut the price target from $53 to $46 on May 11, 2023. This analyst has an accuracy rate of 76%.
- Baird analyst David Koning maintained an Outperform rating and cut the price target from $54 to $48 on May 11, 2023. This analyst has an accuracy rate of 67%.
Read This Next: Investor Sentiment Declines After Moody's Downgrades Credit Ratings Of Banks
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.